CompletedNot Applicable

Efficacy of Magnetotherapy in Hand Erosive Osteoarthritis.

19 participantsStarted 2016-01-02

Plain-language summary

Erosive arthritis (EA) is an unusual pathology. There is no definitive treatment and the conventional one has little efficacy. Despite using magnetotherapy (MGT) as a treatment, there is no evidence supporting its use.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients of both sexes older than 18 years with symptomatic hand erosive osteoarthritis for more than 6 months. * Patients receiving treatment or not for their hand pathology. * Patients suffering from hand chronic pain due to their pathology and scoring VAS equal or greater than 4/10. * Patients who voluntarily signed the informed consent and agree to participate in the study. Exclusion Criteria: * Pregnancy * Patients with pacemaker or similar devices * Pacients with cognitive dysfunction. * Patients with psychiatric pathologies unable to comply with the treatment and follow-up * Patients with active oncological and / or infectious pathology * Patients with previous magnetotherapy or paraffin treatment in the last year

What they're measuring

Visual Analogue Scale (VAS)

Timeframe: Change from baseline pain at the end of the intervention and 3 months after the end of intervention.

Trial details

NCT IDNCT03805113

SponsorHospital Mutua de Terrassa

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-05-01

View on ClinicalTrials.gov More Musculoskeletal Disease trials